Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is an endocrinologic condition affecting one in five women of reproductive age. PCOS is often characterized by disruptions to the menstrual cycle, development of male-pattern hair growth (hirsutism), and polycystic ovary morphology. Recently, PCOS has been linked to metabolic dysfunction, with 40 to 80% of women characterized as overweight or obese. Despite these well-known negative health effects of PCOS, 75% of sufferers remain undiagnosed. This is most likely due to the variability in symptom presentation and the lack of a definitive test for the condition. Metabolomics, which is a platform used to analyze and characterize a large number of metabolites, has recently been proposed as a potential tool for investigating the metabolic pathways that could be involved in the pathophysiology of PCOS. In doing so, novel biomarkers could be identified to improve diagnosis and treatment of PCOS. This review aims to summarize the findings of recent metabolomic studies that highlight metabolic-specific molecules which are deranged in PCOS, to identify potential biomarkers for the condition. Current limitations for metabolomic studies are discussed, as well as future directions to progress the field toward further validation and integration into clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lifestyle interventions, particularly dietary modifications, are widely recommended as first-line treatments to improve symptoms and enhance the overall quality of life in women with PCOS [160].”
Citations
Cites
1 retracted
(2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1290071 · Cited by 59
RetractedAyala, A., Muñoz, M. F., & Argüelles, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/360438 · Cited by 6,349
HMDB 4.0: the human metabolome database for 2018
Wishart, D. S., Feunang, Y. D., Marcu, A., Guo, A. C., Liang, K., Vázquez-Fresno, R., Sajed, T., Johnson, D., Li, C., Karu, N., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1089 · Cited by 3,438
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Multi-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Metabolomics by numbers: acquiring and understanding global metabolite data
Goodacre, R., Vaidyanathan, S., Dunn, W. B., Harrigan, G. G., & Kell, D. B. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.03.007 · Cited by 1,249
Interplay between lipids and branched-chain amino acids in development of insulin resistance
Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.024 · Cited by 1,080
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
Cited by
Yin, G., Chen, F., Chen, G., Yang, X., Huang, Q., Chen, L., Chen, M., Zhang, W., Ou, M., Cao, M., et al. (2022) · Journal of Ovarian Research · doi:10.1186/s13048-022-01051-8 · Cited by 38
“Metabolomics is a useful method to discover and identify metabolites involved in disease [19, 20].”
BackgroundMethodMuhammed Saeed, A. A., Noreen, S., Awlqadr, F. H., Farooq, M. I., Qadeer, M., Rai, N., Farag, H. A., & Saeed, M. N. (2025) · Journal of Health, Population and Nutrition · doi:10.1186/s41043-025-00899-y · Cited by 29
“Lifestyle interventions, particularly dietary modifications, are widely recommended as first-line treatments to improve symptoms and enhance the overall quality of life in women with PCOS [160].”
Yu, J., Zhou, Y., Ding, J., Zhang, D., Yu, C., & Huang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.970733 · Cited by 31
Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome
Yang, Z., Cai, X., Xu, X., Xu, Z., Ye, S., Wang, Y., Hong, Y., Shen, B., Liao, Q., Xie, Z., et al. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114665 · Cited by 22
Chen, J.-Y., Chen, W.-J., Zhu, Z.-Y., Shi, X., Huang, L.-L., Tan, W.-Q., Zhang, Y., & Zhao, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0313494 · Cited by 23
Metadata
- Authors
- Alesi, S., Ghelani, D., & Mousa, A.
- Affiliations
- Monash University (AU)
- Corresponding author
- Mousa, Aya
- Venue
- Seminars in Reproductive Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 2021-05-04
- Volume
- 39
- Issue
- 03/04
- Pages
- 102-110
- ISSN
- 1526-4564 (ISSN-L)
- 1526-8004
- OpenAlex
- W3158687051
- Cited by
- 16
- References
- 87
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 2 · 2023: 4 · 2022: 3
- FWCI
- 0.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Reproductive Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, metabolomic biomarkers, metabolic dysfunction, PCOS diagnosis, metabolic pathways, obesity, hirsutism, metabolic biomarkers
- MeSH terms
- Female, Humans, Male, Polycystic Ovary Syndrome, Biomarkers, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence. https://app.cochat.ai/papers/10.1055/s-0041-1729841
- The paper
- Alesi, S., Ghelani, D., & Mousa, A. (2021). Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence. Seminars in Reproductive Medicine. https://doi.org/10.1055/s-0041-1729841
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.